2/23
08:01 am
rnaz
TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
Low
Report
TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
2/5
08:46 am
rnaz
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138 [Yahoo! Finance]
High
Report
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138 [Yahoo! Finance]
2/5
08:04 am
rnaz
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
High
Report
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
1/24
05:10 am
rnaz
TransCode Therapeutics (NASDAQ:RNAZ) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
High
Report
TransCode Therapeutics (NASDAQ:RNAZ) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
1/6
08:37 am
rnaz
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma [Yahoo! Finance]
Medium
Report
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma [Yahoo! Finance]
1/6
08:01 am
rnaz
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
Medium
Report
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
12/22
08:39 am
rnaz
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors [Yahoo! Finance]
Medium
Report
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors [Yahoo! Finance]
12/22
08:01 am
rnaz
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors
Medium
Report
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors
2/23
08:11 am
rnaz
Form 8-K Transcode Therapeutics, For: Feb 23
Low
Report
Form 8-K Transcode Therapeutics, For: Feb 23
2/5
08:11 am
rnaz
Form 8-K Transcode Therapeutics, For: Feb 05
Low
Report
Form 8-K Transcode Therapeutics, For: Feb 05
1/7
12:39 pm
rnaz
Form SCHEDULE 13G/A Transcode Therapeutics, Filed by: SABBY MANAGEMENT, LLC
Low
Report
Form SCHEDULE 13G/A Transcode Therapeutics, Filed by: SABBY MANAGEMENT, LLC
1/6
08:04 am
rnaz
Form 8-K Transcode Therapeutics, For: Jan 06
High
Report
Form 8-K Transcode Therapeutics, For: Jan 06
12/23
04:17 pm
rnaz
Form DEFA14A Transcode Therapeutics,
Medium
Report
Form DEFA14A Transcode Therapeutics,
12/23
04:16 pm
rnaz
Form 8-K/A Transcode Therapeutics, For: Oct 08
Medium
Report
Form 8-K/A Transcode Therapeutics, For: Oct 08
12/23
06:03 am
rnaz
Form EFFECT Transcode Therapeutics,
Medium
Report
Form EFFECT Transcode Therapeutics,
12/22
04:40 pm
rnaz
Form 3 Transcode Therapeutics, For: Oct 06 Filed by: CZEREPAK ELIZABETH
Low
Report
Form 3 Transcode Therapeutics, For: Oct 06 Filed by: CZEREPAK ELIZABETH
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register